The Patent Finder
US

Stabilizing Alkylglycoside Compositions and Methods Thereof

US 8,076,290 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Feb 28, 2028 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Nov 9, 2007 as application 11/937,966 · Granted Dec 13, 2011
Base term plus 615 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2006 2028
Clock starts
Jun 23, 2006
Ends no later than
Feb 28, 2028
Granted
Dec 13, 2011
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
615
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 615 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 23, 2006, when application 11/474,055, the earliest non-provisional in its chain, was filed (this one was filed Nov 9, 2007)Jun 23, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+615 days, USPTO patent term adjustment recordFeb 28, 2028High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Feb 28, 2028Medium confidence

This family

US 7,425,542Term ended
Jun 2026
Jun 2026
US 8,076,290this patent
no later than Feb 2028
no later than Feb 2028
US 8,084,022In force
no later than Apr 2027
no later than Apr 2027
US 7,998,927Term ended
Nov 2026
Nov 2026
US 8,133,863In force
Sep 2027
Sep 2027
US 8,173,594In force
no later than May 2027
no later than May 2027
US 8,226,949In force
Jun 2027
Jun 2027
US 8,772,231Term ended
Aug 2026
Aug 2026
8 of 11 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 6, 2021
Reel 54823, frame 549
Maggio, Edward T.Aegis Therapeutics, LLCAssignment of Assignor's Interest
Aug 6, 2021
Reel 57111, frame 242
Neurelis, Inc.; Aegis Therapeutics, LLCOrbimed Royalty & Credit Opportunities III, LPSecurity Interest
Nov 14, 2024
reel/frame not recorded
Orbimed Royalty & Credit Opportunities III, LPNeurelis, Inc.Release of Security Interest
Nov 14, 2024
reel/frame not recorded
Orbimed Royalty & Credit Opportunities III, LPAegis Therapeutics, LLCRelease of Security Interest
Nov 14, 2024
Reel 69359, frame 921
Orbimed Royalty & Credit Opportunities III, LPNeurelis, Inc.; Aegis Therapeutics, LLCRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited